| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
|
Lancet Oncol
|
2008
|
2.76
|
|
2
|
Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial.
|
Br J Psychiatry
|
2008
|
2.45
|
|
3
|
Methodological quality of economic evaluations of new pharmaceuticals in The Netherlands.
|
Pharmacoeconomics
|
2012
|
1.79
|
|
4
|
Utilities of the EQ-5D: transferable or not?
|
Pharmacoeconomics
|
2009
|
1.74
|
|
5
|
What do international pharmacoeconomic guidelines say about economic data transferability?
|
Value Health
|
2010
|
1.74
|
|
6
|
Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.
|
Arthritis Rheum
|
2004
|
1.55
|
|
7
|
Does fast-track treatment lead to a decrease of intensive care unit and hospital length of stay in coronary artery bypass patients? A meta-regression of randomized clinical trials.
|
Crit Care Med
|
2006
|
1.49
|
|
8
|
Short-stay intensive care after coronary artery bypass surgery: randomized clinical trial on safety and cost-effectiveness.
|
Crit Care Med
|
2006
|
1.44
|
|
9
|
The burden of illness of rheumatoid arthritis.
|
Clin Rheumatol
|
2011
|
1.43
|
|
10
|
Process evaluation of a multifaceted intervention to improve cardiovascular disease prevention in general practice.
|
Eur J Gen Pract
|
2003
|
1.43
|
|
11
|
Cost-effectiveness of ablation surgery in patients with atrial fibrillation undergoing cardiac surgery.
|
Interact Cardiovasc Thorac Surg
|
2010
|
1.42
|
|
12
|
Healthcare financing systems for increasing the use of tobacco dependence treatment.
|
Cochrane Database Syst Rev
|
2009
|
1.30
|
|
13
|
The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies.
|
Value Health
|
2007
|
1.23
|
|
14
|
Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial.
|
BMC Fam Pract
|
2007
|
1.22
|
|
15
|
Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial.
|
CMAJ
|
2009
|
1.16
|
|
16
|
How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
|
Radiother Oncol
|
2010
|
1.15
|
|
17
|
Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments.
|
Health Qual Life Outcomes
|
2007
|
1.14
|
|
18
|
Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.
|
Ann Rheum Dis
|
2010
|
1.11
|
|
19
|
Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes.
|
Health Econ
|
2005
|
1.10
|
|
20
|
The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.
|
Cancer Treat Rev
|
2010
|
1.08
|
|
21
|
Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy.
|
Br J Psychiatry
|
2008
|
1.08
|
|
22
|
Does a joint development and dissemination of multidisciplinary guidelines improve prescribing behaviour: a pre/post study with concurrent control group and a randomised trial.
|
BMC Health Serv Res
|
2006
|
1.06
|
|
23
|
The relationship between productivity and health-related QOL: an exploration.
|
Pharmacoeconomics
|
2005
|
1.04
|
|
24
|
Vitalum study design: RCT evaluating the efficacy of tailored print communication and telephone motivational interviewing on multiple health behaviors.
|
BMC Public Health
|
2008
|
1.02
|
|
25
|
Economic evaluations of healthcare programmes and decision making: the influence of economic evaluations on different healthcare decision-making levels.
|
Pharmacoeconomics
|
2005
|
1.01
|
|
26
|
Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
|
Hum Reprod
|
2009
|
0.99
|
|
27
|
The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.
|
Value Health
|
2010
|
0.93
|
|
28
|
Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.
|
Soc Sci Med
|
2012
|
0.93
|
|
29
|
The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension.
|
Acta Ophthalmol
|
2013
|
0.92
|
|
30
|
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.
|
Pharmacoeconomics
|
2013
|
0.92
|
|
31
|
Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial.
|
Arch Gen Psychiatry
|
2009
|
0.92
|
|
32
|
Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis.
|
BMC Health Serv Res
|
2008
|
0.92
|
|
33
|
Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.
|
Value Health
|
2011
|
0.92
|
|
34
|
Diagnostic and economic evaluation of new biomarkers for Alzheimer's disease: the research protocol of a prospective cohort study.
|
BMC Neurol
|
2012
|
0.92
|
|
35
|
Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
|
J Clin Oncol
|
2008
|
0.90
|
|
36
|
Determinants of care costs of patients with dementia or cognitive impairment.
|
Alzheimer Dis Assoc Disord
|
2013
|
0.90
|
|
37
|
Considered judgement in evidence-based guideline development.
|
Int J Qual Health Care
|
2006
|
0.90
|
|
38
|
Predictive factors for the objective burden of informal care in people with dementia: a systematic review.
|
Alzheimer Dis Assoc Disord
|
2012
|
0.90
|
|
39
|
The relationship between productivity and health-related quality of life: an empirical exploration in persons with low back pain.
|
Qual Life Res
|
2005
|
0.89
|
|
40
|
Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial.
|
Int J Behav Nutr Phys Act
|
2010
|
0.89
|
|
41
|
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
|
Acta Ophthalmol
|
2012
|
0.89
|
|
42
|
Implementing guidelines into clinical practice: what is the value?
|
J Eval Clin Pract
|
2010
|
0.88
|
|
43
|
Difficulties in calculating productivity costs: work disability associated with borderline personality disorder.
|
Value Health
|
2007
|
0.88
|
|
44
|
Design and evaluation of a computer reminder system to improve prescribing behaviour of GPs.
|
Stud Health Technol Inform
|
2006
|
0.88
|
|
45
|
More is not always better: cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain.
|
Eur J Pain
|
2008
|
0.88
|
|
46
|
Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: results of a randomised controlled trial.
|
Cost Eff Resour Alloc
|
2007
|
0.87
|
|
47
|
Cost effectiveness of an adherence-improving programme in hypertensive patients.
|
Pharmacoeconomics
|
2007
|
0.87
|
|
48
|
Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
|
Pharmacoeconomics
|
2006
|
0.86
|
|
49
|
Clinical and cost-effectiveness of computerised cognitive behavioural therapy for depression in primary care: design of a randomised trial.
|
BMC Public Health
|
2008
|
0.86
|
|
50
|
The effectiveness of nurse-led telemonitoring of asthma: results of a randomized controlled trial.
|
J Eval Clin Pract
|
2008
|
0.86
|
|
51
|
How to deal with cost differences at baseline.
|
Pharmacoeconomics
|
2009
|
0.85
|
|
52
|
Differences in preferences for obstetric care between nulliparae and their partners in the Netherlands: a discrete-choice experiment.
|
J Psychosom Obstet Gynaecol
|
2010
|
0.84
|
|
53
|
Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign.
|
Acta Oncol
|
2014
|
0.84
|
|
54
|
Exploring non-health outcomes of health promotion: the perspective of participants in a lifestyle behaviour change intervention.
|
Health Policy
|
2012
|
0.84
|
|
55
|
Transferability of model-based economic evaluations: the case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands.
|
Value Health
|
2010
|
0.83
|
|
56
|
Cost analysis of the Dutch obstetric system: low-risk nulliparous women preferring home or short-stay hospital birth--a prospective non-randomised controlled study.
|
BMC Health Serv Res
|
2009
|
0.83
|
|
57
|
Long term costs and effects of reducing the number of twin pregnancies in IVF by single embryo transfer: the TwinSing study.
|
BMC Pediatr
|
2010
|
0.83
|
|
58
|
Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable?
|
Pharmacoeconomics
|
2012
|
0.83
|
|
59
|
Value for money in changing clinical practice: should decisions about guidelines and implementation strategies be made sequentially or simultaneously?
|
Med Decis Making
|
2009
|
0.83
|
|
60
|
Effects of a behaviour independent financial incentive on prescribing behaviour of general practitioners.
|
J Eval Clin Pract
|
2007
|
0.82
|
|
61
|
Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
|
Med Care
|
2009
|
0.82
|
|
62
|
Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer.
|
Radiology
|
2009
|
0.81
|
|
63
|
Using EQ-5D in children with asthma, rheumatic disorders, diabetes, and speech/language and/or hearing disorders.
|
Int J Technol Assess Health Care
|
2009
|
0.81
|
|
64
|
Cost-effectiveness of self-management in asthma: a systematic review of peak flow monitoring interventions.
|
Int J Technol Assess Health Care
|
2006
|
0.81
|
|
65
|
Cost-effectiveness of infant orthopedic treatment regarding speech in patients with complete unilateral cleft lip and palate: a randomized three-center trial in the Netherlands (Dutchcleft).
|
Cleft Palate Craniofac J
|
2004
|
0.81
|
|
66
|
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
|
J Antimicrob Chemother
|
2007
|
0.81
|
|
67
|
Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma.
|
Value Health
|
2010
|
0.81
|
|
68
|
Health-related quality of life after fast-track treatment results from a randomized controlled clinical equivalence trial.
|
Qual Life Res
|
2010
|
0.80
|
|
69
|
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
|
Acta Ophthalmol
|
2010
|
0.80
|
|
70
|
Clinical impact of the use of additional ultrasonography in diagnostic breast imaging.
|
Eur Radiol
|
2008
|
0.80
|
|
71
|
A systematic review of model-based economic evaluations of diagnostic and therapeutic strategies for lower extremity artery disease.
|
Thromb Haemost
|
2013
|
0.80
|
|
72
|
A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
0.80
|
|
73
|
The impact of structural uncertainty on cost-effectiveness models for adjuvant endocrine breast cancer treatments: the need for disease-specific model standardization and improved guidance.
|
Pharmacoeconomics
|
2014
|
0.79
|
|
74
|
GP concordance with advice for treatment following a multidisciplinary psychogeriatric assessment.
|
Int J Geriatr Psychiatry
|
2007
|
0.79
|
|
75
|
Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.
|
Pharmacogenet Genomics
|
2007
|
0.79
|
|
76
|
eSET irrespective of the availability of a good-quality embryo in the first cycle only is not effective in reducing overall twin pregnancy rates.
|
Hum Reprod
|
2007
|
0.79
|
|
77
|
Observational studies: a valuable source for data on the true value of RA therapies.
|
Clin Rheumatol
|
2010
|
0.79
|
|
78
|
Specialized rheumatology nurse substitutes for rheumatologists in the diagnostic process of fibromyalgia: a cost-consequence analysis and a randomized controlled trial.
|
J Rheumatol
|
2011
|
0.79
|
|
79
|
Screen or not to screen for peripheral arterial disease: guidance from a decision model.
|
BMC Public Health
|
2014
|
0.79
|
|
80
|
Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.
|
Pharmacoeconomics
|
2014
|
0.78
|
|
81
|
[Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
|
Ned Tijdschr Geneeskd
|
2010
|
0.78
|
|
82
|
During IVF treatment patient preference shifts from singletons towards twins but only a few patients show an actual reversal of preference.
|
Hum Reprod
|
2011
|
0.78
|
|
83
|
Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
|
J Alzheimers Dis
|
2013
|
0.78
|
|
84
|
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.
|
BMC Med Res Methodol
|
2011
|
0.78
|
|
85
|
Reviewing the cost-effectiveness of endocrine early breast cancer therapies: influence of differences in modeling methods on outcomes.
|
Value Health
|
2011
|
0.78
|
|
86
|
The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis.
|
Pharmacoeconomics
|
2006
|
0.78
|
|
87
|
Single versus double embryo transfer: cost-effectiveness analysis alongside a randomized clinical trial.
|
Hum Reprod
|
2006
|
0.78
|
|
88
|
Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.
|
Clin Ther
|
2006
|
0.78
|
|
89
|
One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band.
|
Obes Surg
|
2006
|
0.77
|
|
90
|
Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
|
J Rheumatol
|
2004
|
0.77
|
|
91
|
Efficacy and cost-effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial.
|
BMC Public Health
|
2010
|
0.77
|
|
92
|
The transferability of economic evaluations:testing the model of Welte.
|
Value Health
|
2011
|
0.77
|
|
93
|
Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in R.
|
Med Decis Making
|
2013
|
0.77
|
|
94
|
Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.
|
Pharmacoeconomics
|
2014
|
0.77
|
|
95
|
Costs and effects of ultrasonography in the evaluation of palpable breast masses.
|
Int J Technol Assess Health Care
|
2004
|
0.77
|
|
96
|
The cloudy crystal ball of cost-effectiveness studies.
|
Value Health
|
2013
|
0.76
|
|
97
|
The added value of a multidisciplinary approach in diagnosing dementia: a review.
|
Int J Geriatr Psychiatry
|
2006
|
0.76
|
|
98
|
Ocular hypertension and the risk of blindness.
|
J Glaucoma
|
2015
|
0.76
|
|
99
|
Cost-effectiveness of postural exercise therapy versus physiotherapy in computer screen-workers with early non-specific work-related upper limb disorders (WRULD); a randomized controlled trial.
|
Trials
|
2009
|
0.76
|
|
100
|
High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation.
|
BMC Cardiovasc Disord
|
2014
|
0.76
|
|
101
|
Optimizing the use of expert panel reference diagnoses in diagnostic studies of multidimensional syndromes.
|
BMC Neurol
|
2014
|
0.75
|
|
102
|
Evaluating treatment strategies in patients with early rheumatoid arthritis: merging modeling theory with clinical practice.
|
J Rheumatol
|
2011
|
0.75
|
|
103
|
Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine.
|
J Multidiscip Healthc
|
2013
|
0.75
|
|
104
|
Estimating the implicit value of statistical life based on public interventions implemented in The Netherlands.
|
Int J Technol Assess Health Care
|
2008
|
0.75
|
|
105
|
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.
|
Biomark Med
|
2014
|
0.75
|
|
106
|
Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review.
|
Expert Rev Pharmacoecon Outcomes Res
|
2015
|
0.75
|
|
107
|
Quality of life and costs for different treatment strategies for rheumatoid arthritis.
|
Expert Rev Pharmacoecon Outcomes Res
|
2005
|
0.75
|
|
108
|
[Threshold value for reimbursement of costs of new drugs: cost-effectiveness research and modelling are essential links].
|
Ned Tijdschr Geneeskd
|
2015
|
0.75
|
|
109
|
Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model.
|
Eur J Health Econ
|
2013
|
0.75
|
|
110
|
Exposure to tuberculosis among newborns in a nursery: decision analysis for initiation of prophylaxis.
|
Infect Control Hosp Epidemiol
|
2006
|
0.75
|